JonathanSKatzMD
Neurology • San Francisco, CANeurophysiology
Neurologist, Sutter Pacific Medical Foundation Forbes-Norris MDA/ALS
Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2324 Sacramento St
Ste 111
San Francisco, CA 94115Phone+1 415-600-3604Fax+1 415-673-5184
Education & Training
University of WashingtonResidency, Neurology, 1989 - 1992
Tulane University School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1995 - 2025
TX State Medical License 1993 - 1995
WA State Medical License 1989 - 1994- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Nov 21
- Clinical Trial Nuedexta in Subjects With ALS Start of enrollment: 2013 Apr 01
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 248 citationsTrial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott
The New England Journal of Medicine. 2020-09-02 - 106 citationsValidation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, Volkan Granit, Jeffrey Statland
Neurology. 2020-07-07 - 17 citationsMultisystem neuronal involvement and sicca complex: broadening the spectrum of complications.Jonathan S. Katz, D. Houroupian, Mark A. Ross
Muscle & Nerve. 1999-03-01
Press Mentions
Former Chiropractic Employees Describe What They Say Happened Behind the Scenes at Superior Health CentersSeptember 14th, 2021
Peace over Promise: ALS Patient Quits Taking Drug Aimed at Slowing DiseaseMarch 8th, 2019
First FDA-Approved Treatment for ALS in 22 Years Now Available in U.S.August 8th, 2017- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
